Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.27 HKD | -5.32% | -12.32% | -38.03% |
16/05 | InnoCare Pharma Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis | CI |
14/05 | Innocare Pharma Posts Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.03% | 1.14B | |
+8.38% | 115B | |
+10.13% | 105B | |
-11.69% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-16.00% | 16.01B | |
+2.28% | 14.14B | |
+20.54% | 10.71B |
- Stock Market
- Equities
- 9969 Stock
- News InnoCare Pharma Limited
- Innocare Pharma Posts Q1 Loss